Synthesis of fluorescent-maghemite nanoparticles as multimodal imaging agents for amyloid-β fibrils detection and removal by a magnetic field

Keyphrases

• Alzheimer's Disease 50%
• Alzheimer's Disease Diagnosis 50%
• Amyloid Fibrils 100%
• Amyloid Plaques 100%
• Amyloid Protein 50%
• Clinical Symptoms 50%
• Complete Removal 50%
• Congo Red 50%
• Continuous Phase 50%
• Dementia 50%
• Diagnosis Study 50%
• Early Detection 50%
• Early Diagnosis 50%
• Fluorescence Imaging 50%
• Fluorescence Microscopy 50%
• Fluorescent Magnetic Nanoparticles 50%
• Fluorescent-magnetic 50%
• Human Brain 50%
• Huntington's Disease 50%
• Hybrid System 50%
• Imaging Agents 50%
• In Vivo Imaging 50%
• Iron Oxide 100%
• Mad Cow Disease 50%
• Maghemite Nanoparticles 100%
• Magnetic Fe2O3 50%
• Magnetic Field 100%
• Magnetic Imaging 50%
• Multimodal Imaging Agent 100%
• Nanoparticles 50%
• Nanostructured Systems 50%
• Neurodegenerative Diseases 50%
• Neuronal Damage 50%
• Non-fluorescent 50%
• Parkinson 50%
• Plaque 50%
• Prion Disease 50%
• Rhodamine B (Rh B) 50%
• Specific Biomarkers 50%

Neuroscience

• Alzheimer's Disease 66%
• Amyloid 100%
• Amyloid Protein 33%
• Bovine Spongiform Encephalopathy 33%
• In Vivo 66%
• Magnetic Resonance Imaging 33%
• Neurodegenerative Disorder 33%
• Transmissible Spongiform Encephalopathy 33%

Material Science

• Density 33%
• Fluorescence Microscopy 33%
• Magnetic Nanoparticle 33%
• Magnetic Resonance Imaging 33%
• Nanoparticle 100%